Journal of Basic and Clinical Pharmacy received 13553 citations as per google scholar report
Glycemic management is a critical aspect of patient care, and numerous
studies suggest that hyperglycemia has been linked to poor inpatient
outcomes such as infection, prolonged hospital stay, disability after
discharge, and death [1]. Patients with Blood Glucose (BG) levels >198
mg/dL at admission were associated with higher risk of mortality.
Currently, the American Diabetes Association (ADA) recommends a
glycemic target of 140-180 mg/dL in the majority of non-critically ill
patients with a more stringent goal of 110-140 mg/dL as an option in
selected patients without significant hypoglycemic risks. Computer
based algorithms for delivery of intravenous insulin such as the
Glucommander® program support beneficial outcomes associated with
reducing BG variability and episodes of hypoglycemia, especially during
hyperglycemic crises such as diabetic ketoacidosis or hyperosmolar
hyperglycemic state when strict glycemic control is desired [2].